These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 25840282

  • 1. Rheumatoid arthritis: Biological therapy other than anti-TNF.
    Rossi D, Modena V, Sciascia S, Roccatello D.
    Int Immunopharmacol; 2015 Aug; 27(2):185-8. PubMed ID: 25840282
    [Abstract] [Full Text] [Related]

  • 2. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Bae SC.
    Int J Rheum Dis; 2016 Nov; 19(11):1103-1111. PubMed ID: 26692536
    [Abstract] [Full Text] [Related]

  • 3. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors].
    Swierkot J, Madej M.
    Pol Merkur Lekarski; 2011 Apr; 30(178):289-94. PubMed ID: 21595177
    [Abstract] [Full Text] [Related]

  • 4. [New therapies for rheumatoid arthritis].
    Salgado E, Maneiro JR.
    Med Clin (Barc); 2014 Nov 18; 143(10):461-6. PubMed ID: 24461738
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis.
    Huoponen S, Aaltonen KJ, Viikinkoski J, Rutanen J, Relas H, Taimen K, Puolakka K, Nordström D, Blom M.
    PLoS One; 2019 Nov 18; 14(7):e0220142. PubMed ID: 31339961
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study.
    Pascart T, Philippe P, Drumez E, Deprez X, Cortet B, Duhamel A, Houvenagel E, Flipo RM.
    Int J Rheum Dis; 2016 Nov 18; 19(11):1093-1102. PubMed ID: 27018857
    [Abstract] [Full Text] [Related]

  • 7. Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study.
    Curtis JR, Sarsour K, Napalkov P, Costa LA, Schulman KL.
    Arthritis Res Ther; 2015 Nov 11; 17():319. PubMed ID: 26555431
    [Abstract] [Full Text] [Related]

  • 8. Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis.
    Shan J, Zhang J.
    Joint Bone Spine; 2019 Mar 11; 86(2):173-183. PubMed ID: 29635017
    [Abstract] [Full Text] [Related]

  • 9. New therapeutic options in rheumatoid arthritis: a focus on interleukin-6 blockade.
    Furfaro N.
    J Infus Nurs; 2011 Mar 11; 34(2):107-15. PubMed ID: 21399456
    [Abstract] [Full Text] [Related]

  • 10. Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response.
    Gibbons LJ, Hyrich KL.
    BioDrugs; 2009 Mar 11; 23(2):111-24. PubMed ID: 19489652
    [Abstract] [Full Text] [Related]

  • 11. The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.
    Provan SA, Berg IJ, Hammer HB, Mathiessen A, Kvien TK, Semb AG.
    PLoS One; 2015 Mar 11; 10(6):e0130709. PubMed ID: 26114946
    [Abstract] [Full Text] [Related]

  • 12. Overall infection risk in rheumatoid arthritis during treatment with abatacept, rituximab and tocilizumab; an observational cohort study.
    Grøn KL, Glintborg B, Nørgaard M, Mehnert F, Østergaard M, Dreyer L, Krogh NS, Hetland ML.
    Rheumatology (Oxford); 2020 Aug 01; 59(8):1949-1956. PubMed ID: 31764977
    [Abstract] [Full Text] [Related]

  • 13. [Proposal for biologic drugs therapy in rheumatoid arthritis].
    Curković B, Babić-Naglić D, Morović-Vergles J, Anić B, Grazio S, Kaliterna DM, Hanih M, Novak S.
    Reumatizam; 2010 Aug 01; 57(1):29-35. PubMed ID: 20941938
    [Abstract] [Full Text] [Related]

  • 14. The use of biologic therapies in the treatment of rheumatoid arthritis.
    Wang D, Li Y, Liu Y, Shi G.
    Curr Pharm Biotechnol; 2014 Aug 01; 15(6):542-8. PubMed ID: 25213363
    [Abstract] [Full Text] [Related]

  • 15. Targeted therapy in rheumatoid arthritis.
    Köller MD.
    Wien Med Wochenschr; 2006 Jan 01; 156(1-2):53-60. PubMed ID: 16465614
    [Abstract] [Full Text] [Related]

  • 16. Tumour necrosis factor α antagonists in the treatment of rheumatoid arthritis: an immunological perspective.
    Meroni PL, Valesini G.
    BioDrugs; 2014 Apr 01; 28 Suppl 1():S5-13. PubMed ID: 24687234
    [Abstract] [Full Text] [Related]

  • 17. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers.
    Mercer LK, Askling J, Raaschou P, Dixon WG, Dreyer L, Hetland ML, Strangfeld A, Zink A, Mariette X, Finckh A, Canhao H, Iannone F, Zavada J, Morel J, Gottenberg JE, Hyrich KL, Listing J.
    Ann Rheum Dis; 2017 Feb 01; 76(2):386-391. PubMed ID: 27307502
    [Abstract] [Full Text] [Related]

  • 18. Safety profile of biological therapies for treating rheumatoid arthritis.
    Cañete JD, Hernández MV, Sanmartí R.
    Expert Opin Biol Ther; 2017 Sep 01; 17(9):1089-1103. PubMed ID: 28657381
    [Abstract] [Full Text] [Related]

  • 19. Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
    Favalli EG, Biggioggero M, Marchesoni A, Meroni PL.
    Rheumatology (Oxford); 2014 Sep 01; 53(9):1664-8. PubMed ID: 24729445
    [Abstract] [Full Text] [Related]

  • 20. Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis.
    Papagoras C, Voulgari PV, Drosos AA.
    Autoimmun Rev; 2010 Jun 01; 9(8):574-82. PubMed ID: 20433955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.